Many new names sounded as if they’d been cooked up by a medieval monk. HIV-1 would henceforth be known as Lentivirus ...
On Friday he announced that he and MyoKardia’s executive team have raised $300 million for a new heart disease company, ...
The changes reflect “a cultural shift” around obesity medications, said Diana Zuckerman, president of the nonprofit National ...
Basic public health protections help augment our national security protections,” particularly when it comes to emerging ...
Eli Lilly is partnering with the fabled venture capital firm Andreessen Horowitz on a new fund backed with $500 million of ...
Documents show Robert F. Kennedy Jr. invested in biotech companies and consulted on health care — interests he might have to ...
The Biden administration’s final regulation affecting the Medicare Advantage industry would come with a much lighter touch ...
Enrollment of Black and Hispanic students in medical schools dropped precipitously last year after the Supreme Court banned ...
Patrizia Cavazzoni, leader of the FDA's Center for Drug Evaluation and Research, is leaving the agency on Jan. 18.
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry ...
The White House gives agencies more leeway with one of the few tools against meth use: financial incentives, or "contingency ...